Creo Medical Share Price | |
---|---|
Price | 34.75 |
Bid | 34.50 |
Ask | 35.00 |
Change | -0.50 (-1.42%) |
Volume | 113,485 |
Open | 35.25 |
High | 35.25 |
Low | 34.75 |
Prev. Close | 35.25 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 361.48m |
Market Capitalisation | £125.61m |
Market Size | 10,000 |
52 Week High | 49.00 |
52 Week High Date | 02-Jan-2024 |
52 Week Low | 23.25 |
52 Week Low Date | 08-Jun-2023 |
# Trades | 26 |
---|---|
Vol. Sold | 13,677 |
Sold Value | £4.81k |
Vol. Bought | 97,808 |
Bought Value | £34.39k |
PE Ratio | -2.400459 |
Earnings | -14.4764 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
03-May-24 | 14:45:18 | 34.95 | 25,000 | Buy* | 34.50 | 35.00 | 8,738 | O Ordinary |
03-May-24 | 14:16:13 | 34.98 | 9,000 | Buy* | 34.50 | 35.00 | 3,148 | O Ordinary |
03-May-24 | 14:16:12 | 35.00 | 100 | Buy* | 34.50 | 35.00 | 35.00 | O Ordinary Trade was executed as an SI |
03-May-24 | 13:47:42 | 34.86 | 1,485 | Sell* | 34.50 | 35.50 | 517.67 | O Ordinary |
03-May-24 | 13:18:52 | 35.175 | 537 | Buy* | 34.50 | 35.50 | 188.89 | O Ordinary |
03-May-24 | 13:17:20 | 35.175 | 14,382 | Buy* | 34.50 | 35.50 | 5,059 | O Ordinary |
03-May-24 | 12:24:03 | 35.175 | 9,935 | Buy* | 34.50 | 35.50 | 3,495 | O Ordinary |
03-May-24 | 12:17:17 | 35.175 | 1,219 | Buy* | 34.50 | 35.50 | 428.78 | O Ordinary |
03-May-24 | 12:09:48 | 35.50 | 3 | Buy* | 34.50 | 35.50 | 1.07 | O Ordinary Trade was executed as an SI |
03-May-24 | 12:09:48 | 34.50 | 27 | Sell* | 34.50 | 35.50 | 9.32 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
13-Mar-23 | 09-Mar-23 | Buy | Ivonne Cantu held the position of Independent Non-Executive Director at the time of this trade.Ivonne Cantu | 20.00 | GBX | 125,000 | 125,000 |
13-Mar-23 | 09-Mar-23 | Buy | John Bradshaw held the position of Independent Non-Executive Director at the time of this trade.John Bradshaw | 20.00 | GBX | 1,265,135 | 1,371,082 |
13-Mar-23 | 09-Mar-23 | Buy | David Gerard Woods held the position of Executive Director at the time of this trade.David Gerard Woods | 20.00 | GBX | 415,255 | 440,255 |
13-Mar-23 | 09-Mar-23 | Buy | Christopher Paul Hancock held the position of Chief Technology Officer at the time of this trade.Christopher Paul Hancock | 20.00 | GBX | 383,171 | 4,802,352 |
13-Mar-23 | 09-Mar-23 | Buy | Richard John Rees held the position of CFO at the time of this trade.Richard John Rees | 20.00 | GBX | 2,715,322 | 2,805,902 |